Among patients with stage III melanoma with occult lymph node metastasis who choose to not undergo completion lymph node dissection...

Patients treated for Merkel cell carcinoma (MCC) face a five-year recurrence rate of 40%—markedly higher than the recurrence rates for...

A cross-sectional survey study in the U.S. has identified differences in skin cancer risk factors among Asian American individuals. The...

Findings from a new study suggest that inhibiting both the LAG-3 and PD-1 immune checkpoints in patients with previously untreated...

Findings from a pilot trial suggest that after excision of localized melanoma, patient-led surveillance appears to be safe, feasible and...

New research published at the NCRI (National Cancer Research Institute) Festival suggests that the images and accompanying data currently...

One in five Brits will develop an NMSC in their lifetime A new study has attempted to stratify the impact of non-melanoma skin cancer...

The rates of keratinocyte carcinomas (KCs) in Ontario, Canada increased 30% between 2003 and 2017. These findings come from a paper...